Medical Devices - Newport Beach, California, United States
Embic Corporation develops digital cognitive biomarkers, which can resolve urgent problems in multiple healthcare channels, including the pre-symptomatic identification of Alzheimer's Disease. To generate these biomarkers, Embic has deployed a brief cognitive test battery on an electronic platform enabling efficient test administration, automatic data collection, and real-time delivery of results generated by proprietary scoring algorithms. This battery has been administered nearly two million times by its clients, and the database of responses comprises a growing normative dataset for ongoing R&D. From this dataset, Embic has recently developed proprietary algorithms for quantifying the unobservable cognitive processes of information encoding and retrieval. These new digital biomarkers will have a profound impact on clinical care, diagnostics, and the field of Alzheimer's research. Embic's analytic algorithms have been validated through medical journal publications, NIH grants, and industry adoption.
reCAPTCHA
Gmail
Wordpress.com
Google Font API
Shutterstock